TA'NEKA LINDSAY: Open Payments
NPI 1912184714 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,044 in 29 payments from 17 companies in 2025. Trend: 2023 $592 · 2024 $947 · 2025 $1,044
Food & beverage: $1,044
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 1 | $169 |
| Axsome Therapeutics, Inc. | 2 | $141 |
| EVOKE PHARMA, INC. | 1 | $125 |
| ABBVIE INC. | 2 | $119 |
| ABIOMED | 1 | $94 |
| Novo Nordisk Inc | 3 | $60 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Amgen Inc. | 3 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Medtronic, Inc. | 2 | $39 |
Products named: OMNIPOD, Auvelity, GIMOTI, CAPLYTA, Ozempic, MINIMED 780G, Heplisav-B, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
